The pharmaceutical packaging industry has evolved significantly in recent years as new technologies and pioneering solutions have been developed to meet changing market requirements. Additionally, companies continue to explore ways to drive efficiencies across the supply chain, streamline their operations, and reduce time to market.
Serialisation
Over the last few years we have seen the implementation of serialisation regulations within the pharma industry, in response to the number of counterfeit products entering the supply chain. These new regulations that now exist in multiple markets aim to combat this issue by making drug products verifiable as they pass through the supply chain, ensuring greater safety for patients.
In February 2019, regulators implemented the EU Falsified Medicines Directive (FMD). The regulation introduced new requirements for manufacturers whereby they are now expected to ensure products are affixed with a unique serial number and barcode. This guarantees each product’s shelf life, batch number, and origin are traceable and that products can be verified as legitimate at the point of dispense to the patient.
|
.jpg)
